“The approval of SRP and SNAP in Israel and the appointment of Eli Moshe as GM, come at a very pivotal time for Surgical Theater,” said Moty Avisar, CEO and Co-Founder of Surgical Theater. “We are very excited to grow our global presence and have no doubt Mr. Moshe will be a great catalyst in accelerating that growth. Increasing numbers of surgeons across the world will be able to use this novel technology to advance the way they perform surgeries.”

Read more here.